TY - JOUR AU - Saravanan, M. AU - Premalatha, N. AU - Ramkumar, P. K. AU - Kannan, K. AU - Apoorva, R. AU - Venkatesan, M. AU - Jayalshmi, K. AU - Yogeshpriya, S. AU - Senthilkumar, S. PY - 2021/03/24 Y2 - 2024/03/29 TI - Reversal of Hepato-renal Impairment Induced by Meloxicam Paracetamol Toxicity in a Labrador Dog JF - Toxicology International JA - TI VL - 28 IS - 1 SE - Original Research DO - 10.18311/ti/2021/v28i1/26394 UR - https://www.informaticsjournals.com/index.php/toxi/article/view/26394 SP - 81-89 AB - An 8 years old male Labrador dog was referred to Small animal Medicine Referral Clinic, Veterinary Clinical complex, Veterinary College and Research Institute, Orathanadu for fever, anorexia, hematemesis and melenic stools. The dog on treatment with 2 ml of Meloxicam Paracetamol combination IM, along with Injection Oxytetracycline and fluid therapy for 3 days by locally and did not respond to treatment thus was referred. Clinical dullness, lethargy, respiratory distress, visible mucosal jaundice, ecchymosis on ventral abdomen was noticed. Physical examination revealed, halitosis, ulceration in the tip of the tongue, dehydration, pre scapular LN enlargement, distended abdomen, fluid thrill and splenomegaly. Hematology revealed anemia and thrombocytopenia. Biochemical analysis revealed Hyperbilirubinemia, Elevated BUN, Creatinine, AST, ALT, ALP and hypoalbuminemia. Abdominal ultrasound reveled splenomegaly, focal hyperechoic liver parenchyma, cortex echogenicity of right kidney and perirenal fluid accumulation. ECG revealed peaked T wave. Radiography revealed hepatosplenomegaly. Hemato-biochemical alteration was monitored before and after therapy. Animal was managed with fluid therapy, Acetylcysteine, Amino acid and supportives and the dog had an uneventful recovery. ER -